![Mike Henos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mike Henos
Plus aucun poste en cours
Profil
Mr. Mike A. Henos is General Partner & at Alliance Technology Ventures, and Co-Founder at ProMed Technologies, Inc. Prior to founding ATV in 1993, Mr. Henon was a General Partner with Aspen Venture Partners, where he was based in Menlo Park, CA. Prior to Aspen he was Vice President of 3i Ventures in Newport Beach, CA. From 1984 to 1986, he was a health care consultant with Ernst & Young, specializing in venture financing of start-up medical technology companies.
Prior to 1984, he served in a variety of management positions with Science Applications, the Revlon Healthcare Group and co-founded Pro Med Technologies, where he also served as its Chief Executive Officer.
He earned a BS in economics and an MBA from the University of California at Los Angeles (UCLA).
Anciens postes connus de Mike Henos
| Sociétés | Poste | Fin |
|---|---|---|
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Président | 13/02/2012 |
Sensys Medical Ltd.
 Sensys Medical Ltd. Medical DistributorsDistribution Services Develops and manufactures blood glucose monitoring devices | Directeur/Membre du Conseil | 03/03/2011 |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Directeur/Membre du Conseil | 01/02/2011 |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Directeur/Membre du Conseil | 13/10/2009 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Président | 14/07/2009 |
Formation de Mike Henos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Sensys Medical Ltd.
Sensys Medical Ltd. Medical DistributorsDistribution Services Develops and manufactures blood glucose monitoring devices | Distribution Services |
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aspen Ventures
 Aspen Ventures Investment ManagersFinance Aspen Ventures looks for opportunities to invest in early-stage information technology companies located in the Western US, particularly those serving business markets. The firm does not invest in companies focused on consumer markets. Potential investments are evaluated against criteria that include compelling technology-based solutions that are differentiated and address large markets, entrepreneurial Management team and a well-formulated strategy. | Finance |
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Alliance Technology Management Corp.
 Alliance Technology Management Corp. Investment ManagersFinance Alliance Technology Ventures focuses on investments in early-stage private companies located in the US. The firm targets companies operating in the field’s semiconductor, communication component and life science industries. They provide financing for seed, early, later stage capital requirements. | Finance |
ProMed Technologies, Inc. | |
3i Ventures Corp. |
